Literature DB >> 14991627

Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer.

C W Wu1, C A Hsiung, S S Lo, M C Hsieh, L T Shia, J Whang-Peng.   

Abstract

BACKGROUND: A randomized comparison of D1 (level 1 lymphadenectomy) and D3 (levels 1, 2 and 3 lymphadenectomy) dissection was performed to evaluate morbidity and effects on survival from gastric cancer.
METHODS: A total of 221 patients were studied after resection for gastric cancer, 110 after D1 surgery and 111 after D3 surgery.
RESULTS: The morbidity rate was higher after D3 than after D1 resection (17.1 (95 per cent confidence interval (c.i.) 10.1 to 24.1) versus 7.3 (95 per cent c.i. 2.4 to 12.2) per cent respectively; P = 0.012). The difference was largely related to abdominal abscess (8.1 per cent after D3 versus none after D1 resection; P = 0.003). The D3 group had an anastomotic leak rate of 4.5 per cent whereas there was no leakage in the D1 group (P = 0.060). All anastomotic leaks were minor and were managed non-operatively with nutritional support. Patients who had D3 resection had longer operating times, greater blood loss and postoperative drain outputs, and more patients needed blood transfusion. There was no death in either group. The hospital stay was longer after D3 than D1 surgery (mean(s.d.) 19.6(13.9) (range 10-98) versus 15.0(4.0) (range 10-30) days; P = 0.001).
CONCLUSION: Extended lymphadenectomy for gastric cancer is associated with more complications than limited lymphadectomy but this does not lead to significant mortality. Copyright 2004 British Journal of Surgery Society Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 14991627     DOI: 10.1002/bjs.4433

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  49 in total

1.  Intra-abdominal infectious complications following gastrectomy in patients with excessive visceral fat.

Authors:  Norihiko Sugisawa; Masanori Tokunaga; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masanori Terashima
Journal:  Gastric Cancer       Date:  2011-10-13       Impact factor: 7.370

2.  Definition and classification of complications of gastrectomy for gastric cancer based on the accordion severity grading system.

Authors:  Mi Ran Jung; Young Kyu Park; Jang Won Seon; Kwang Yong Kim; Oh Cheong; Seong Yeob Ryu
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

Review 3.  Current management of gastric cancer.

Authors:  Ulf H Haglund; Bengt Wallner
Journal:  J Gastrointest Surg       Date:  2004-11       Impact factor: 3.452

4.  Complications following D3 gastrectomy: post hoc analysis of a randomized trial.

Authors:  Chew-Wun Wu; I-Shou Chang; Su-shun Lo; Mao-Chin Hsieh; Jen-Hao Chen; Wing-Yiu Lui; Jacqueline Whang-Peng
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

5.  How does epidemiological and clinicopathological features affect survival after gastrectomy for gastric cancer patients-single Egyptian center experience.

Authors:  Ehab El Hanafy; Ayman El Nakeeb; Helmy Ezzat; Emad Hamdy; Ehab Atif; Tharwat Kandil; Amgad Fouad; Mohamed Abdel Wahab; Ahmed Monier
Journal:  World J Gastrointest Surg       Date:  2016-06-27

Review 6.  Surgical management of gastric cancer: the East vs. West perspective.

Authors:  Maki Yamamoto; Omar M Rashid; Joyce Wong
Journal:  J Gastrointest Oncol       Date:  2015-02

7.  Reduction of hospital stay and cost after the implementation of a clinical pathway for radical gastrectomy for gastric cancer.

Authors:  Jimmy B Y So; Ziliang L Lim; Heng-An Lin; Thiow-Kong Ti
Journal:  Gastric Cancer       Date:  2008-07-02       Impact factor: 7.370

8.  Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis.

Authors:  Jingyu Deng; Han Liang; Dan Sun; Yi Pan; Yong Liu; Dianchang Wang
Journal:  Langenbecks Arch Surg       Date:  2011-03-05       Impact factor: 3.445

9.  Feasibility and safety of laparoscopy-assisted distal gastrectomy performed by trainees supervised by an experienced qualified surgeon.

Authors:  Takanobu Yamada; Yuta Kumazu; Masato Nakazono; Kentaro Hara; Shinsuke Nagasawa; Yota Shimoda; Tsutomu Hayashi; Yasushi Rino; Munetaka Masuda; Manabu Shiozawa; Soichiro Morinaga; Takashi Ogata; Takashi Oshima
Journal:  Surg Endosc       Date:  2019-04-09       Impact factor: 4.584

10.  Results of specialization in the surgical treatment of gastric cancer in Peru.

Authors:  Michel Portanova; Fernando Vargas; Emilio Lombardi; Victor Mena; Ramiro Carbajal; Nestor Palacios; Jorge Orrego
Journal:  Gastric Cancer       Date:  2007-06-25       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.